1. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351: 1451–1467, 1998
2. Berger U, Wilson P, McClelland R, Colston K, Haussler MR, Pike JW, Coombes RC: Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in primary breast cancer. Cancer Res 47: 6793–6795, 1987
3. Berger U, McClelland RA, Wilson P, Greene GL, Haussler MR, Pike JW, Colston K, Easton D, Coombes RC: Immunocytochemical detection of estrogen receptor, progesterone receptor and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relation to prognosis. Cancer Res 51: 239–244, 1991
4. Colston KW, Mørk Hansen C: Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Rel Cancer 9: 45–59, 2002
5. Mørk Hansen C, Binderup L, Hamberg KJ, Carlberg C: Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Frontiers Biosci 6: 820–848, 2001